Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 6 of 25

ACTIVE NOT RECRUITING NA

Photodynamic Therapy Incubation Times for Actinic Keratosis

NCT03066843

ACTIVE NOT RECRUITING NA

PDL and Fractional Photothermolysis for Postsurgical Scars

NCT03057964

ACTIVE NOT RECRUITING Phase 2

Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

NCT03012321

ACTIVE NOT RECRUITING NA

Pain Perception: Lidocaine Rate/Temp/Buffer

NCT02823002

ACTIVE NOT RECRUITING NA

Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite

NCT02427698

ACTIVE NOT RECRUITING Phase 2

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT02232516

ACTIVE NOT RECRUITING Phase 2

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

NCT02993198

ACTIVE NOT RECRUITING Early Phase 1

The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser

NCT02427724

ACTIVE NOT RECRUITING NA

A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma

NCT01976286

ACTIVE NOT RECRUITING Phase 4

Ice Versus EMLA for Pain in Laser Hair Removal

NCT02318654

ACTIVE NOT RECRUITING Phase 4

Treatment of Facial Flushing With Botulinum Toxin A Injections

NCT02216838

ACTIVE NOT RECRUITING NA

Effect of Multiple Subcisions on Rolling Acne Scars

NCT02216864

ACTIVE NOT RECRUITING Early Phase 1

A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles

NCT02019004

ACTIVE NOT RECRUITING Phase 2

A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars

NCT01976260

ACTIVE NOT RECRUITING Phase 1

A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction

NCT01976247

ACTIVE NOT RECRUITING

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

NCT01782703

ACTIVE NOT RECRUITING Early Phase 1

Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

NCT01722916

ACTIVE NOT RECRUITING NA

Effect of Subcision and Suction on Acne Scars

NCT01696513

ACTIVE NOT RECRUITING

Patient Satisfaction in Cutaneous Surgery

NCT01535963

ACTIVE NOT RECRUITING Phase 3

A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients

NCT01897688

ACTIVE NOT RECRUITING Early Phase 1

Fractional Laser vs. Ultrasound for Periorbital Wrinkles

NCT01529983

ACTIVE NOT RECRUITING Phase 4

Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection

NCT01688076

ACTIVE NOT RECRUITING

Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type

NCT01688063

ACTIVE NOT RECRUITING Phase 2

Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

NCT01361711

ACTIVE NOT RECRUITING Phase 1

Effect of Platelet Rich Plasma on Photoaged Skin

NCT01372566

ACTIVE NOT RECRUITING NA

Study of the Carbon Dioxide Treatment for Fat Reduction

NCT00974415

ACTIVE NOT RECRUITING

Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients

NCT00856895

NOT YET RECRUITING Phase 2

Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

NCT07639528

NOT YET RECRUITING Phase 1

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

NCT07594626

NOT YET RECRUITING Phase 1

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

NCT07594548

NOT YET RECRUITING Phase 1

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

NCT06545695

NOT YET RECRUITING NA

Use of a Vibration Tool for Postoperative Pain Control in Distal Radius Fractures

NCT05318729

NOT YET RECRUITING Early Phase 1

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT05728879

NOT YET RECRUITING NA

Personalized Prosthetic Foot Prescription and Rehabilitation for Veterans With Lower Limb Loss

NCT06844305

NOT YET RECRUITING NA

ALDH2 Genetic Testing in East Asian Community

NCT07392775

NOT YET RECRUITING Phase 2

PDT vs Peels for Treatment of Actinic Keratoses

NCT04429308

NOT YET RECRUITING NA

Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Illinois Primary Health Care Association (COMMUNITY ASPIRE)

NCT06886776

NOT YET RECRUITING Early Phase 1

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

NCT07410312

NOT YET RECRUITING

Implementation of AIP Services for Older Adults With AD

NCT07361601

NOT YET RECRUITING NA

Parents and Babies Pilot

NCT07607613

NOT YET RECRUITING NA

Emsella for Reducing tSUI After HOLEP

NCT07580404

NOT YET RECRUITING NA

Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

NCT07469176

NOT YET RECRUITING Phase 2

Valproic AcId for Traumatic BRAin INjury Trial

NCT07166393

NOT YET RECRUITING Phase 2

Defining the Ablative Dose for Y-90 TARE

NCT07586046

NOT YET RECRUITING NA

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

NCT07324772

NOT YET RECRUITING NA

Scaling Out S.A.F.E. Firearm Across Two Health Systems as a Universal Suicide Prevention Strategy (SCALE ASPIRE)

NCT07009314

COMPLETED Early Phase 1

Feasibility of a Mental-Health Intervention Based on Contemplative Sleep Practices

NCT07217340

COMPLETED NA

A Single-Session Intervention Fostering Emotional Nonreactivity

NCT07034027

COMPLETED

Vasomotor Symptoms in Post-Hysterectomy Women With Ovarian Conservation

NCT07064850

COMPLETED NA

EHR Nudges to Improve Quality of Care in HF

NCT06103565

← Previous Page 6 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.